Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Salek

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Emerging Guidelines for Patient Engagement in ResearchJohn R Kirwan, Maarten de Wit, Lori Frank, et al.
Frontiers in Medicine|September 13, 2021
Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving ForwardTariro Sithole, Gugu Mahlangu, Velma Capote, et al.
Frontiers in Pharmacology|September 25, 2025
Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the middle East and Africa: a cross-sectional studySam Salek, Hani Sabbour, Naji Alamuddin, et al.
Drug Safety|March 28, 2023
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing TrendsNelly F Ly, Clare Flach, Thom S Lysen, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Diabetes, Obesity & Metabolism|February 13, 2023
A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationaleSubodh Verma, Hani Sabbour, Naji Alamuddin, et al.
Multiple Sclerosis and Related Disorders|May 22, 2022
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosisPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Neurodegenerative Disease Management|July 26, 2024
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summaryPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Frontiers in Pharmacology|July 5, 2024
Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King's College, London and the GMDP Academy, New YorkHonorio Silva, Peter Stonier, Pravin Chopra, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Emerging Guidelines for Patient Engagement in ResearchJohn R Kirwan, Maarten de Wit, Lori Frank, et al.
Frontiers in Medicine|September 13, 2021
Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving ForwardTariro Sithole, Gugu Mahlangu, Velma Capote, et al.
Frontiers in Pharmacology|September 25, 2025
Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the middle East and Africa: a cross-sectional studySam Salek, Hani Sabbour, Naji Alamuddin, et al.
Drug Safety|March 28, 2023
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing TrendsNelly F Ly, Clare Flach, Thom S Lysen, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Diabetes, Obesity & Metabolism|February 13, 2023
A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationaleSubodh Verma, Hani Sabbour, Naji Alamuddin, et al.
Multiple Sclerosis and Related Disorders|May 22, 2022
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosisPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Neurodegenerative Disease Management|July 26, 2024
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summaryPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Frontiers in Pharmacology|July 5, 2024
Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King's College, London and the GMDP Academy, New YorkHonorio Silva, Peter Stonier, Pravin Chopra, et al.
Pageof 15